StockData
Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc. (MRVI) stock

MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.40−0.14 (-1.86%)

Close on Nov 16, 2026Market cap $1.92BP/E –Yield –

Maravai LifeSciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Maravai LifeSciences's enterprise value was $1.35B on Nov 11, 2026, against $755.30M a year earlier. Over the last 5 years it ranged from $504.02M to $10.28B, with a median of $1.38B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.35B+92.6%
2025Dec 31, 2025$702.19M-26.1%
2024Dec 31, 2024$949.67M-31.4%
2023Dec 29, 2023$1.38B-60.1%
2022Dec 30, 2022$3.47B-60.7%
2021Jan 29, 2021$8.82B+24.3%
2020Dec 31, 2020$7.10B–

More Maravai LifeSciences figures

See a number that looks wrong?